CIK 0001231457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GENELUX Corp
Sign in to watch- Ticker
- GNLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 805-267-9889
- Business address
- 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $155,693
- in 6 filings
Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | Szalay Aladar 10% owner | Sale | −23,920 | $26.21 | $627K | 8,247 |
| 2023-09-19 | Szalay Aladar 10% owner | Sale | −8,247 | $27.16 | $224K | 0 |
| 2023-09-18 | Szalay Aladar 10% owner | Sale | −27,365 | $23.20 | $635K | 7,927 |
| 2023-09-18 | Szalay Aladar 10% owner | Sale | −2,927 | $24.17 | $71K | 5,000 |
| 2023-09-18 | Thomas John Director | Sale | −3,334 | $24.99 | $83K | 475,793 |
| 2023-09-15 | Yu Yong VP, Clinical Trial Operations | Exercise or conversion | +10,400 | $6.00 | $62K | 116,535 |
| 2023-09-15 | Yu Yong VP, Clinical Trial Operations | Sale | −5,725 | $21.56 | $123K | 110,810 |
| 2023-09-15 | Yu Yong VP, Clinical Trial Operations | Sale | −4,675 | $22.29 | $104K | 106,135 |
| 2023-09-15 | Yu Yong VP, Clinical Trial Operations | Exercise or conversion · Stock Option (right to buy) | −10,400 | 229,253 | ||
| 2023-09-15 | Thomas John Director | Sale | −2,245 | $21.67 | $49K | 480,215 |
| 2023-09-15 | Thomas John Director | Sale | −1,088 | $22.38 | $24K | 479,127 |
| 2023-09-14 | Szalay Aladar 10% owner | Sale | −11,405 | $21.77 | $248K | 49,163 |
| 2023-09-14 | Szalay Aladar 10% owner | Sale | −13,871 | $22.31 | $310K | 35,292 |
| 2023-09-13 | Yu Yong VP, Clinical Trial Operations | Sale | −29,800 | $21.14 | $630K | 106,135 |
| 2023-09-13 | Szalay Aladar 10% owner | Sale | −15,717 | $21.26 | $334K | 63,883 |
| 2023-09-13 | Szalay Aladar 10% owner | Sale | −3,315 | $22.31 | $74K | 60,568 |
| 2023-09-13 | Smither John W Director | Sale | −900 | $20.78 | $19K | 6,920 |
| 2023-09-12 | Szalay Aladar 10% owner | Sale | −6,538 | $21.75 | $142K | 93,327 |
| 2023-09-12 | Szalay Aladar 10% owner | Sale | −13,727 | $22.51 | $309K | 79,600 |
| 2023-09-11 | Zindrick Thomas President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 |
Page 13 of 16 · 315 trades